Longevity Acceleration Podcast Longevity Biotech Fellowship

Jean Hebert is a professor of genetics and neuroscience at the Albert Einstein College of Medicine, and the founder of BE Therapeutics. In this interview, he discusses his strategy of replacing ageing as a pathway to longevity, shifting focus from genetics to brain tissue replacement due to ageing complexities. He emphasizes the potential of gene delivery technology and brain replacement for longevity.
The conversation covers tissue replacement, particularly cortical tissue, and other brain structures like the hypothalamus. Jean addresses surgery challenges, the need for improved techniques, and estimated costs of $3 to $10 billion. We also discuss reversible cryostasis, advancements in cryopreservation, and the ethical implications of brain replacement and destructive uploading, alongside strategies to attract talent and funding to the longevity field.

Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeutics. He is a long-standing and well-connected patient advocate for aging research, involved in numerous fundraising and outreach initiatives conducted by organizations such as the Methuselah Foundation and SENS Research Foundation since the early 2000s. He is also the founder and writer of Fight Aging!, a noted news and commentary website in the biotechnology community. Prior to his involvement in the biotechnology industry, Reason was a consultant in the software industry. He holds Masters degrees in Astrophysics from the University of St. Andrews and Space Physics from Rice University.

Is there a plan to cure aging? No concrete plan exists on the websites of the National Institute on Aging or any longevity biotech company website.



But we need a plan. Solving aging is one of the most challenging and meaningful technological achievements humanity will ever undertake.



Mark Hamalainen and Nathan Cheng, the co-directors of the Longevity Biotech Fellowship, introduce an outline for a technical roadmap to solve aging and the accompanying podcast series.

A deep dive conversation with José Luis Ricon (Head of Theory @ Retro Bioscience, blogger @ Nintil.com).



José explains his mental model for understanding aging and the strategies and technologies that could extend healthy lifespan by 10 years -- or much much more...